Main Innovation Point
QQ-piPSC technology generates protein-induced pluripotent stem cells (piPSCs), by which reprogramming proteins only transiently modulate molecular pathways of the normal somatic cells or diseased cells including cancer cells epigenetically for cell phenotype conversion into piPSCs and no trace of delivered exogenous materials remaining in the generated piPSCs.
Due to nearly 100% cell conversion efficiency, QQ-piPSC technology uses full dish cell culture in the whole cells reprogramming process to generate piPSC, without clone selection and expansion.This method eliminated possible gene mutation and other side effect that are related to clone selection, and generated iPS cells are safe in future clinical application.
440 Burroughs Street, Ste 448;Detroit, MI 48202, USA
001 618 201 4310
Asia Pacific Headquarters:
Fuent Biotechnology Co. Ltd (Shanghai)
12A, Junyao International Plaza, No. 789, Zhaojiabang Road, Shanghai